Mycoplasma Genitalium NAAT: The Hidden STI and Testing Methods
Mycoplasma Genitalium is a slow-growing bacterium that causes non-gonococcal urethritis and pelvic inflammatory disease. It can only be detected via NAAT urine or swab assays. Paying cash keeps this advanced infectious screen off your insurance history.
This article describes blood diagnostics, public health reporting mandates, and record containment options. It is not clinical diagnostic advice or treatment instruction. Cash pay shields your commercial insurance profile but does not circumvent state infectious disease reporting laws for positive results.
The Emerging Threat of Mycoplasma Genitalium
Mycoplasma genitalium (Mgen) is a sexually transmitted bacterium that lacks a cell wall, making standard antibiotics like penicillin completely ineffective. It is a leading cause of persistent urethritis in men and pelvic inflammatory disease (PID) in women. Because Mgen grows incredibly slowly, standard bacterial cultures cannot detect it; it requires a specialized Nucleic Acid Amplification Test (NAAT).
Reporting Norms and Medical Privacy
Because Mgen is an emerging STI, it is not currently listed as a mandatory reportable condition in most states. This means positive results do not trigger automated state public health database entries. When combined with cash pay, Mgen screening offers absolute clinical privacy, preventing any external insurance system from logging your diagnosis.
Managing Resistance and Private Screening
Mgen has developed significant resistance to azithromycin, meaning specialized testing is often required to check for macrolide resistance markers. Ordering this test privately via cash pay allows you to secure accurate data and seek targeted treatment without compromising your long-term health insurance files.
Frequently Asked Questions
Q: Why did my Chlamydia/Gonorrhea test come back negative but I still have symptoms?
A: Mycoplasma genitalium causes identical symptoms (burning, discharge) and is frequently the cause of urethritis when other tests are negative.
Q: What is the recommended antibiotic treatment for M. genitalium?
A: Treatment typically involves a two-stage approach using doxycycline followed by moxifloxacin, due to high rates of antibiotic resistance.